Advantage Investment Management’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$0 Hold
125
﹤0.01% 917
2019
Q2
$1K Hold
125
﹤0.01% 896
2019
Q1
$0 Hold
125
﹤0.01% 932
2018
Q4
$0 Hold
125
﹤0.01% 994
2018
Q3
$1K Hold
125
﹤0.01% 966
2018
Q2
$1K Hold
125
﹤0.01% 899
2018
Q1
$1K Hold
125
﹤0.01% 940
2017
Q4
$1K Sell
125
-1,000
-89% -$8.34K ﹤0.01% 951
2017
Q3
$9K Hold
1,125
﹤0.01% 710
2017
Q2
$5K Hold
1,125
﹤0.01% 829
2017
Q1
$4K Buy
1,125
+1,000
+800% +$3.96K ﹤0.01% 827
2016
Q4
$1K Sell
125
-825
-87% -$3.37K ﹤0.01% 893
2016
Q3
$4K Sell
950
-250
-21% -$1.29K ﹤0.01% 755
2016
Q2
$6K Hold
1,200
﹤0.01% 667
2016
Q1
$14K Buy
1,200
+125
+12% +$1.74K 0.01% 508
2015
Q4
$21K Hold
1,075
0.01% 455
2015
Q3
$26K Sell
1,075
-165
-13% -$4.29K 0.01% 406
2015
Q2
$32K Hold
1,240
0.02% 403
2015
Q1
$30K Buy
1,240
+990
+396% +$25K 0.02% 402
2014
Q4
$6K Buy
+250
New +$6.51K ﹤0.01% 596

Other funds holding CLMT

Advantage Investment Management's CLMT Position: Q3 2019 in Review

Advantage Investment Management held its Calumet Specialty Products (CLMT) position steady in Q3 2019 at 125 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #917.

Advantage Investment Management first reported a position in CLMT in Q4 2014 and has held it in 20 quarters since. The position peaked at $32K in Q2 2015. 65 funds tracked by Wall St. Rank hold CLMT as of Q3 2019.

  • Advantage Investment Management held 125 shares of Calumet Specialty Products worth $0 as of Q3 2019.
  • Advantage Investment Management left its Calumet Specialty Products share count unchanged in Q3 2019.
  • Calumet Specialty Products made up ﹤0.01% of Advantage Investment Management's portfolio in Q3 2019, its #917 holding.
  • Advantage Investment Management first reported a position in Calumet Specialty Products in Q4 2014 and has held it in 20 quarters since.
  • Advantage Investment Management's Calumet Specialty Products position peaked at $32K in Q2 2015.
  • 65 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.